Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors

Most anticancer therapies to date focus on druggable features of tumor epithelia. Despite the increasing repertoire of treatment options, patient responses remain varied. Moreover, tumor resistance and relapse remain persistent clinical challenges. These observations imply an incomplete understandin...

Полное описание

Библиографические подробности
Главные авторы: Chan, Jeremy Soon Kiat, Sng, Ming Keat, Teo, Zi Qiang, Chong, Han Chung, Twang, Jing Shun, Tan, Nguan Soon
Другие авторы: School of Biological Sciences
Формат: Journal Article
Язык:English
Опубликовано: 2019
Предметы:
Online-ссылка:https://hdl.handle.net/10356/90275
http://hdl.handle.net/10220/48495